Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.4145 | 91 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.11355 | 89 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.58396 | 92 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.32656 | 90 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.38155 | 90 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.65583 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.41739 | 92 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.0493 | 89 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.46922 | 91 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.31739 | 90 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.65921 | 92 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.46567 | 91 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.6545 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.51049 | 92 |